Conspiracy Theory Posited Over Shire’s Withdrawal Of BLA For Fabry Disease Drug

This article was originally published in The Pink Sheet Daily

15 Jul 2014
News

Brenda Sandburg @brendasandburg Brenda.Sandburg@informa.com

Executive Summary

Knowledge Ecology International suggests Shire pulled its Replagal BLA in return for rights to Mount Sinai School of Medicine patent that could have blocked sales in Europe; asks FTC to investigate “possible conspiracy” between school, Shire and Sanofi.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Industries
BioPharmaceutical
Subjects
Regulation

Related Companies

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

BioPharmaceutical Regulation

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS077438

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS077438

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Conspiracy Theory Posited Over Shire’s Withdrawal Of BLA For Fabry Disease Drug

News

Executive Summary

Related Content

Shire Withdraws Replagal BLA Rather Than Conduct Lengthy Trials – Updated

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert